AIR Global PLC (AIIR) Earnings Call Transcript & Summary
August 20, 2026
Earnings Call Speaker Segments
Gaurav Jain
executiveGood morning, everyone, and thanks for being here on AIR Global PLC's 1H 2026 earnings call — the first one we've held since our Nasdaq listing on May 18, 2026. Joining me are Stuart Brazier, our CEO, and Bassem Lotfy, our CFO; once the prepared remarks wrap up, we'll open the line for questions. We put out our first half earnings press release this morning, and you can find all the materials on our website, ir.air.global, as well as on the SEC's site, sec.gov. A recording of this webcast will be available for listening later on today as well. During today's discussion, we'll be making forward-looking statements that reflect what we currently expect and the information we have. Those statements carry risks and uncertainties, and many of them lie outside the company's control. AIR Global undertakes no obligation to revise forward-looking statements unless the law requires it. I'd ask you to look over the safe harbor statements and risk factors included in today's press release and in our latest filings with the SEC, which provide further detail and describe risks that could cause actual results to differ materially from what our forward-looking statements anticipate. We'll be reporting results on an IFRS basis as well as a non-IFRS basis. You'll find non-IFRS measures such as adjusted EBITDA, along with their IFRS reconciliations, laid out in our press release. Non-IFRS financial measures shouldn't be treated as a replacement for the results we report under IFRS; with that said, I'll hand things over to Stuart.
Stuart Brazier
executiveThanks, Gaurav, and hello everyone. We're glad you could be with us for AIR Global's inaugural earnings call since becoming a public company. For AIR, this marks a significant milestone; our Nasdaq listing happened in May, and today we're sharing our initial interim results as a listed business. Before we get into performance, I want to take a moment to recognize the team propelling AIR forward. Among AIR's biggest assets is how deep and varied our leadership is. Throughout our executive ranks, we combine decades of know-how drawn from worldwide consumer goods, tobacco, innovation, technology, supply chain, and regulatory entities. Together, our leaders have run some of the biggest consumer brands on the planet, overseen intricate cross-border operations, and steered successfully through heavily regulated sectors. That range of expertise mattered greatly in stretches such as the first half of 2026, when supply chain upheaval was unprecedented and market conditions shifted rapidly. Notably, a number of our leaders have collaborated for years and have come through numerous business cycles, regulatory regimes, and eras of industry transformation. As we move into our next chapter as a public company, I'm confident AIR possesses the right people, culture, and capabilities to keep producing sustainable growth and long-term shareholder value. AIR is a worldwide consumer brand and innovation company, built on the foundation of the leading flavored shisha molasses business globally, while increasingly assembling a portfolio of next-generation inhalation and nicotine products. Our core business stands apart. Via Al Fakher, we hold the top position worldwide in flavored shisha molasses. In the markets where we compete, we believe we exceed the next four competitors put together, holding an estimated 36%-44% of global volume, and occupying very strong positions in key markets, among them the United States, where our share is estimated at roughly 60%-65%. This category is driven by social, cultural, and lifestyle factors. It's enjoyed in homes and lounges spanning generations and geographies, and it isn't merely a nicotine delivery occasion. That matters, since it gives the category a demand profile unlike many traditional tobacco categories. The category is fundamentally different from most traditional tobacco segments. Although almost every major traditional tobacco category in the U.S. has seen substantial volume declines over the past several years, flavored shisha has stayed remarkably resilient, with Al Fakher's volume trends stable to modestly positive. This mirrors the category's unique character. Consumers aren't just buying nicotine. They're taking part in a social, cultural, and lifestyle experience shared with friends and family, frequently in lounges, restaurants, and social gatherings. Consequently, demand has historically held up across a broad range of economic and industry environments. That resilience is further supported by the strength of the Al Fakher brand. We estimate Al Fakher reaches roughly 14 million consumers worldwide, placing it among the most recognized tobacco and nicotine brands globally. Even though we compete in a space investors frequently pass over, the number of consumers we touch is large and keeps growing. What matters more is our belief that holding the top position gives us real competitive edges. Across numerous key markets we hold leading share, we benefit from deep customer loyalty, we have robust flavor innovation skills, and we operate a distribution network that would be hard for others to copy. Set against numerous other nicotine offerings and routine discretionary buys, shisha stays a very affordable treat. U.S. consumer spending runs roughly $110 annually, far below cigarettes, where a typical buyer may lay out over $2,000, pod-based vaping items, where buyers typically spend $1,000, or nicotine pouches, where buyers spend $400; from the consumer's standpoint, a small bump in flavored shisha's retail price has a fairly limited effect on total outlay. For AIR, though, such pricing moves can deliver substantial backing for revenue expansion and recovery from inflation. The robust 14% price mix gain we posted in the first half shows both how strong our brands are and how affordable these categories remain. Crucially, we held onto market share even with those pricing moves, which strengthens our belief in the business's potential for long-term earnings growth; during the first half of 2026, we encountered an unmatched supply chain shock when the Strait of Hormuz closed, a corridor carrying roughly 70% of the shipment volumes we have historically moved. Even with that obstacle, we expanded revenue, kept adjusted EBITDA roughly flat, safeguarded end consumer demand, and began the second half with building momentum; now let's discuss 2026 guidance; across full year 2026, we anticipate shipment volumes holding steady against 2025. That comes even with an approximately 1.5% drag from softer global travel retail volumes tied to the Middle East conflict and even with the effect of above-normal pricing put in place to counter elevated cost inflation. We anticipate revenue growth between 4%-6% in U.S. dollars. We anticipate adjusted EBITDA growth in the low to mid-single-digit range. That sits under our historical high single-digit growth trend, and three clear reasons explain it. First, we're taking on added public company costs after the Nasdaq listing. Second, we're speeding up our factory footprint reorganization plan to cut long-term reliance on the Strait of Hormuz. Third, we're also dealing with elevated logistics and raw material costs linked to the Middle East conflict, even though we now have alternative supply routes ready to soften future disruption. Modest gains from U.S. tariff refunds and excise duty drawbacks partly counter these headwinds. Setting aside these cost headwinds, our adjusted EBITDA growth in 2026 would be expected to align with AIR's historical high single-digit EBITDA growth trend; we also anticipate net financing costs staying broadly stable, an effective tax rate near 15%, CapEx between $15 million-$18 million, and net debt to adjusted EBITDA roughly flat at year-end versus 2025, mirroring the IPO-related cash outflows and the Greentank investment. The 2026 outlook and medium-term guidance include no share repurchases. Past 2026, our medium-term framework stays unchanged. Looking ahead to 2027 and across the medium term, our projection is organic FSM shipment volume growth in the low single digits, powered by ongoing share gains and moves into additional markets, and that assumes excise tax hikes stay non-disruptive. For FSM revenue, we anticipate mid-single-digit growth measured in U.S. dollars, while FSM adjusted EBITDA should rise at a high single-digit rate in U.S. dollars. On top of that, we foresee ongoing deleveraging, with net debt to adjusted EBITDA coming down steadily as time passes. A leverage ratio of 2.5x net debt to adjusted EBITDA continues to be our target over the long term. How quickly and how substantially new growth category revenue and adjusted EBITDA contribution arrive will hinge on the FDA accepting our PMTA applications. Discipline will remain a priority for us; we will put money to work wherever we identify technology, science, brand, and regulatory pathways capable of generating durable value. Against that backdrop, I'll pass things to Bassem now so he can take you through the first half financials in greater detail.
Bassem Lotfy
executiveThanks, Stuart, and hello everyone joining us today. My remarks will address how the group performed, how each segment did, the reconciliation from reported EBITDA to adjusted EBITDA, cash flow, leverage, and the other main assumptions behind our outlook. Let me begin with the group's results. Revenue for the first half of 2026 came in at $206.9 million, which is 3.7% higher than the $199.5 million recorded in the first half of 2025. Gross profit reached $116.8 million versus $114 million a year earlier, a gain of 2.4%. Adjusted EBITDA was $71.7 million, essentially unchanged year over year. EBITDA showed a loss of $52.1 million, against positive EBITDA of $61 million in the prior year. We posted an operating loss of $63.6 million, compared with operating profit of $51.5 million in the same period last year. The net loss totaled $81.8 million, and basic EPS came in at — $0.57. The main takeaway here is that underlying trading held up well, even though reported results took a significant hit from one-time listing related and other non-recurring items. Those items don't alter the fundamental strength of the business, but they matter for understanding the numbers, and I'll get to them in a moment. On volume and price mix, FSM shipment volumes fell 9% during the first half. Global travel retail volumes dropped 46.5%. If you set GTR aside, FSM shipment volumes were down 6.6%. As Stuart mentioned, the effect was heaviest in March and April, and volume growth came back in June. Price and mix growth was a robust 14%, reflecting faster pricing moves aimed at countering cost inflation and supply chain pressures. Now to the segments. In the Americas, revenue reached $42.8 million, an increase of 3.4% year over year. Adjusted EBITDA was $19.8 million, up 17.2%. Price and mix drove this result, partially offset by slightly lower volume, with strong cost control providing support. Market conditions remain stable in the United States, our biggest market by revenue, and we anticipate full-year U.S. revenue growth speeding up to high single digits, helped by share gains and innovation. In MEAA, revenue was $136.7 million, up 4%, lifted by high teens price and mix growth. Adjusted EBITDA came to $59.7 million, a decline of 4% year over year. Because MEAA contains global travel retail and our corporate headquarters, the segment felt the impact of higher public company costs as well as greater supply chain costs tied to the Middle East conflict. Crucially, our market shares held firm despite substantial pricing, and Saudi Arabia is delivering share growth; in Europe, revenue was $25.2 million, up 0.4%. Adjusted EBITDA fell to $0.1 million, down from $1.8 million a year ago. Europe is still difficult. Sharp excise tax hikes and weak enforcement have allowed illicit products to spread in certain markets. We stay disciplined in our approach, safeguarding the brand, managing profitability with care, and advocating for enforcement conditions that favor the legal market; in New Growth Categories, revenue was $2.2 million, up 37.5% off a small base, reflecting growth in OOKA and the Crown Switch launch in Europe. Adjusted EBITDA came in at a loss of $7.9 million. That is better than last year's loss of $9.3 million, though it still shows what we are putting into product development and commercialization. As we've noted before, when larger NGC contributions land depends on the regulatory pathways — above all, the FDA accepting PMTA applications in the U.S. Now let me walk from EBITDA to adjusted EBITDA. EBITDA showed a loss of $52.1 million. Adjusted EBITDA stood at $71.7 million. Several items sit in that bridge: some are one-time, some non-cash, some tied to the listing, and some simply don't reflect normalized operating performance. First, we booked $48.2 million of expense tied to equity issued at the listing event, mostly connected to 4.2 million shares given to the SPAC sponsor when we listed. Out of those 4.2 million shares, 2.7 million are vested, while 1.5 million stay subject to price-based earn-out provisions, though they are counted in our issued share count. Second, we took on $47.7 million in IPO related cash costs. Third, we spent $7.4 million on public company readiness costs, covering legal, tax and accounting. Fourth, we booked $3.8 million in extraordinary costs stemming from regional disruption, including air freight and ingredients bought at temporarily elevated prices so operations could continue without interruption. Fifth, we absorbed $2 million in regulatory costs linked to speeding up PMTA filings in the U.S. after the FDA changed its enforcement guidance for nicotine vapes and pouches. On top of that, EBITDA contains $12.4 million of share-based compensation expense, mainly tied to one-time programs set up for senior management around the listing event; these charges are non-cash and will keep being recognized across the remaining vesting period under IFRS. We know the first half carries a big number of adjusting items. As a public company, our aim is to report earnings of the highest quality, where adjusted figures genuinely reflect underlying earnings and cash generation. The listing related expenses won't recur, and they account for most of the gap between reported and adjusted results in the first half. Moving to cash flow and the balance sheet, cash and cash equivalents totaled $85.4 million at June 30, 2026. Total borrowings reached $430.2 million, which puts net debt at $344.8 million. Net debt to adjusted EBITDA was 2.48x, calculated on rolling 12 months adjusted EBITDA. Compared with 2025, we expect net debt to adjusted EBITDA to be broadly stable at the full year 2026 year end, reflecting IPO related cash outflows and the Greentank investment. Our long term leverage target is 2.5x. On working capital and cash conversion, first half operating cash flow took a hit from the disruption, shipment timing, receivables and the cash costs tied to listing. Trade and other receivables rose, mirroring shipment timing and the business dynamics as it came back from the disruption; we expect working capital to normalize as volumes recover and shipments move more evenly across the second half. To repeat what we shared earlier, we'll hold an extraordinary general meeting on August 24, 2026, where shareholders will cast votes on proposals tied to share repurchases—yet our guidance doesn't factor in any repurchase activity. To sum up, the first half shows how resilient AIR's operating model is. Revenue increased even with disruption. Adjusted EBITDA held steady even with substantial cost headwinds. One-time listing related items and other non-recurring items weighed on reported results. We move into the second half with better shipment momentum, alternative supply routes established, and a clear path toward recovery. So with that, I'll turn things back to Stuart.
Stuart Brazier
executiveAppreciate that, Bassem. As we close out the prepared portion of today's call, I want to spend a moment on Greentank and why it matters strategically for us. Back on July 29, 2026, we went public with a plan to put $20 million into Greentank, valuing the company at $170 million before that money comes in. Under the terms of this deal, AIR picks up the ability to lift our stake by an additional 20% over the coming 24 months, priced at a $250 million valuation. Beyond that, we secured the ability to put a director on Greentank's board, landed better commercial terms, gained exposure to new technologies, and locked in long-term supply assurance for Crown Switch. What this investment signals is our conviction that the wider tobacco and nicotine space remains early in its shift toward next-generation categories. About a billion people around the world smoke, and under 150 million of them have transitioned to NGC products. While current alternatives have moved things forward, there are still significant hurdles for consumers, such as how the product feels to use, consistency, how it delivers the sensory experience, confidence in the regulatory side, and worries regarding emissions. The reason Greentank's Quantum Vape platform is significant is that it gives us access to atomization technology that sets us apart; our belief is that this platform can provide an inhalation experience that is cleaner and more pleasurable, and notably, the early scientific findings are promising. AIR presented findings from a study that assessed aerosol emissions from the planned U.S. versions of Crown Switch, which are powered by Greentank's Quantum Vape platform. The study was carried out by McKinney Specialty Labs, a standalone analytical lab located in Richmond, Virginia. The study showed that Crown Switch aerosol has much smaller amounts of multiple harmful and potentially harmful constituents compared with a variety of FDA-authorized ENDS products that are already being sold. Some of what was found is featured in the presentation. No carbon monoxide showed up in any of the variants that were tested. Compared with a mint ENDS product used as a comparator, formaldehyde came in roughly 94% lower. Versus that same mint ENDS comparator, nickel was about 97% lower, and many harmful or potentially harmful constituents registered either as non-detectable or at extremely low amounts. Regulatory review is still necessary — these findings don't replace it — and we are continuing to produce the data our PMTA process calls for, yet the results give us a solid basis for setting the product apart. From a strategic standpoint, Greentank benefits us in four distinct ways. To start, it makes our tech platform stronger. Next, it backs the PMTA filing and the U.S. go-to-market plan for Crown Switch. Then, it secures supply over the long run and opens the door to upcoming vaporization breakthroughs. And lastly, it could deliver financial gains by expanding our stake in a technology platform that we think matters across a wider set of categories. Later this year, we're getting ready to submit our PMTA for Crown Switch, and our intention is to introduce Crown Switch in the U.S. as soon as the FDA accepts that application, assuming all relevant regulatory conditions are met. Over in Europe, Crown Switch is already on the market, and early commercialization is giving us useful lessons. Beyond vapor products, we're developing expertise in nicotine pouches and additional emerging categories, even as we keep funding shisha and the wider set of inhalation innovations we're pursuing. Let me state this plainly. FSM, our primary operation, continues to serve as AIR's bedrock; it delivers strong margins, operates worldwide, is driven by brands, and withstands pressure well. Even so, what gives us assurance is AIR's potential to draw on its brands, its distribution know-how, its ability to create new products, and its disciplined approach to regulation in order to matter meaningfully in the emerging landscape of inhalation and nicotine categories. This investment in Greentank represents a major step forward on that journey. To wrap up, AIR delivered a durable first half even with upheaval at a magnitude unlike anything we've previously encountered. We protected demand, increased revenue, kept adjusted EBITDA level, and took steps that reduce supply chain risk down the road. According to our guidance, the second half should bring quicker growth, shipment volumes will remain unchanged for the entire year, revenue will rise 4%-6%, and adjusted EBITDA will grow in the low to mid-single digit range. Over the medium term, we expect organic FSM volume growth in the low single digits, FSM revenue growth in the mid-single digits, FSM adjusted EBITDA growth in the high single digits, and continued deleveraging. Our brand's strength supports high margins, our global footprint provides diversification, and for consumers our product remains an affordable indulgence. Within the U.S., the money people spend each year on shisha is fairly small when you set it beside what goes toward cigarettes, pod-based vapes, nicotine pouches, and many ordinary discretionary purchases. Beginning this chapter as a publicly traded business is something we're genuinely excited about, and we intend to win investor confidence through steady execution, open communication, and careful deployment of capital. Operator, at this point we're ready to handle questions from the call.
Pallav Mittal
analystHello, and good morning. I appreciate you taking my questions. There are 3 of them, and I'll go through them individually. First, regarding the 2026 guidance, you mention mid-single digit revenue growth, which would basically mean 6% growth in the second half, to reach, let's say, 5% at the midpoint for the full year. Since you're referring to volumes growing high single digit in the second half, could you help us understand the negative price mix element you're observing in the second half?
Stuart Brazier
executiveYes, of course. Thanks for asking. In the first half of the year, you'll see that shipments declined while price mix rose at 14%. What we did was prioritize our high margin markets for supply; so markets like the U.S., markets like Saudi were important to us; we also implemented accelerated pricing, as Bassem has mentioned. We're now in a position where our full pricing for the year has been taken. So in the second half of the year, you'll see that the price mix impact is smaller. That's because the comparator in H2 2025 is tougher than in H1; also, we'll be supplying and the sales will go to lower margin markets, where once again, the price mix impact is smaller. So the effect of the higher volumes is offset by the price mix impact.
Pallav Mittal
analystAbsolutely. And next, regarding the medium-term projection you've mentioned—that 4%-6% revenue growth, which falls in the mid-single digit range—could you break that down into how much comes from volume versus price, and also by geography? You've pointed to the U.S. growing at high single digits this year. Would it be reasonable to conclude that for you, growth in the U.S. along with the Middle East and Africa is significantly stronger, while Europe is more or less flat, or perhaps in the low single digits?
Stuart Brazier
executiveYes. Looking ahead, low single digit volume is what drives revenue; layering pricing on top of that brings us to the mid-single digit guidance. I'd also say it's fair to note that we're seeing quicker growth in the U.S. and the MEAA region, with Europe expanding more slowly.
Pallav Mittal
analystSure — one thing I wanted to ask about is your New Growth Categories. During the first half of this year, the losses came in a bit below where they were a year ago. There isn’t anything in the materials explaining how we ought to frame New Growth Categories or those losses, or when you expect them to become profitable. So should we treat the $20 million loss from 2025 as the peak loss? Or is it possible that number grows as you put more money into new products?
Stuart Brazier
executiveYeah. The biggest opportunity we see, I’d say, is Crown Switch in the U.S. That clearly hinges on our PMTA submission and when it happens. We’re obviously centered on generating sustainable value, and in places where we identify that chance, we will put money in; and where we can speed up profitable growth in those areas, we’ll do that too. But the largest opportunity we see is U.S. Crown Switch; we’ve already rolled out in a few European markets and are expanding our route-to-market capabilities there.
Pallav Mittal
analystAbsolutely. To build on what was just discussed, should we take that to mean you're likely reducing your focus on OOKA along with certain other products that have come up in past conversations?
Stuart Brazier
executiveWhen it comes to OOKA, the intellectual property behind it belongs to us. Clearly, OOKA holds a great deal of importance for our position in the FSM category. Beyond that, it fits into our premiumization approach, since a consumer of OOKA generates more value for us each year than a typical FSM consumer does; in our view, this product is evolving gradually instead of the category undergoing rapid transformation. Let me remind everyone that this category has existed for 600 years, correct? It remains highly steady. We observe low single digit volume growth globally; the demographic tailwind in the Middle East, Africa, Asia, and Western markets is what fuels that, and in the West it's turning into more of a social phenomena, something people enjoy doing with friends. It's social, it's occasional. Yet that is precisely what propels its growth. Still, we do anticipate that over time, OOKA will account for a bigger share of our business; currently it's expanding steadily, and we project that trend will carry on through the midterm.
Gaurav Jain
executivePallav, let me build on a few of those opening questions regarding the price mix dynamic in 2H. During 1H, our focus was on steering volumes toward markets with higher ASPs. In 2H, naturally, volumes will lean more toward markets with lower ASPs. That doesn't mean margins are thinner there — those are simply the lower ASP markets. But taking it all together, that explains the reversal you'll notice in the volume price mix dynamic during 2H. On top of that, the macro remains unsettled, so one could say there's some conservatism baked into the top line guidance we're putting forward. Bear those factors in mind; then when you look at our guidance over the medium term, what we're aiming for is essentially a balanced revenue growth algorithm, one that includes both volume and pricing components. Obviously, our pricing power is phenomenal. You can see that in our 1H results, where we're posting 14% in dollar pricing. That's dollar pricing, not constant currency pricing. The explanation for that is that within this category, we hold the dominant position, so we can essentially determine whatever pricing we choose. That said, we certainly don't want to wield that pricing power annually, since that isn't the right way to build a business for the long term; so our medium-term guidance depends on both elements. It depends on volume growth as well as price as well as a mix element, given that we are premiumizing various parts of our business.
Pallav Mittal
analystExcellent. That's quite useful. I'll rejoin the queue.
Morayo Adesina
analystHello. I appreciate you taking my question. I was hoping you might describe the supply chain interruptions you encountered with a little more specificity, and what precisely are you altering in terms of your logistics or supply chain so as to lessen reliance on the Strait of Hormuz?
Stuart Brazier
executiveYes. Many thanks. As I mentioned before, 70% of our volumes had historically been shipped via the Strait of Hormuz. That route was no longer open to us, which meant we needed to find alternative ports from which we could ship product; so that entailed, within the U.A.E., moving across to the Gulf of Oman, plus routes passing through Saudi from the ports located there, as well as ports out of Oman; so that required adding various logistics, placing products on the road, and sending them through different countries; that covered outgoing. And for ingoing or incoming raw materials, it likewise meant that since certain routes had stopped being dependable, we needed to set up new routes for inbound goods, and in certain instances, several routes, to make sure we obtained our raw materials. Regarding the factory footprint, you'll observe that earlier in the year, we announced we are building a factory in Romania, which clearly diversifies our factory footprint going forward. That work is in progress, and we would anticipate that factory being commissioned by the end of this year and operational in 2027.
Morayo Adesina
analystThank you. That's really useful. Then last thing from me, on Europe — clearly, profits dropped a lot in the first half. So I wanted to ask whether you could elaborate on which dynamics have to shift there before profitability can recover.
Stuart Brazier
executiveSure. Europe has traditionally been quite cyclical, in fact. You usually see excise duty rises take effect from January 1. That sets up a trade pull in Q4, since traders, distributors and wholesalers build inventory before the price goes up. If you look at the past, it's clear the second half consistently outperforms the first half, because you capture that gain. Second, during this year we shifted our U.S. manufacturing to Poland. As mentioned before, we give priority to supplying markets with high prices, or higher prices, and that caused some timing effects on Europe-bound shipments from the Polish plant. So once more, you see that reverse across Q3 and Q4 of this year.
Morayo Adesina
analystExcellent, that's useful. Many thanks.
Pallav Mittal
analystI appreciate you fielding these follow-ups. There are a few additional items I'd like to raise. First, regarding how you deploy capital — it's evident your main operations run on a model with limited CapEx, and you've pointed to net debt to EBITDA of 2.5x as the leverage goal. Based on what we project, it appears you'll come in under 2x before this year wraps up. So when it comes to returning capital to shareholders down the road — whether through buybacks of stock or dividend payments — how should we frame that?
Stuart Brazier
executiveYes, thank you, Pallav. As we've stated, no share buybacks are baked into the guidance. That said, an EGM is scheduled for Monday, and during it, proposals will be put forward that would provide us with the ability to repurchase shares later on should we determine that's the appropriate course. You're spot on. Given the projections we've shared, our gearing will come down as we approach the end of the year. If we choose to proceed, there's a real possibility we'd be positioned to act. Naturally, over the longer term, we aim to give capital back to shareholders whenever we identify a chance to do so.
Gaurav Jain
executiveTo build on what Pallav said, you're correct about the business: capital expenditures are modest, and as you can observe, the tax rate is quite low too. Our free cash flow conversion stands at a fairly elevated level. On top of that, the core business ought to be capable of expanding. Hoarding capital isn't our intention, so every avenue for distributing capital that exists globally will be on the table — share repurchases, dividends, special dividends. Nothing has been announced so far, and naturally, that call belongs to the board. Still, we'll be evaluating every path for capital allocation moving forward.
Pallav Mittal
analystAbsolutely. Let me ask about nicotine pouches, and feel free to set me straight if I've got this wrong. My recollection is that you brought it to the U.S. market around April of this year; so what's the early reaction been, and are other markets starting to open up for nicotine pouches? Lately there's been buzz about Saudi Arabia being a potentially huge market. Do you see anything happening that could support your expansion in nicotine pouches?
Stuart Brazier
executiveYes. That's correct. Our U.S. launch was highly targeted, focused on specific geographies; we're gathering learnings and seeing initial results from it. We've also brought nicotine pouches to Spain not long ago. Once again, we're focusing on particular areas within Spain while we test our messaging with consumers, test trial, and make sure our products reach consumers' hands; but this is still at a very early stage. On Saudi, at present it operates more or less as a monopoly, in fact. So external brands aren't able to get into that market. A product named DZRT exists there and is performing really well, yet it faces no competition. That could shift down the road. Our view is that Saudi would be an excellent market. Since our brand is also very strong in Saudi, it would be a fantastic opportunity should that market open. One of the larger hurdles in the nicotine pouch category, I'd say, is product differentiation; earlier we discussed our enthusiasm and our conviction regarding Crown Switch since it's a differentiated product; our belief is that with good execution, it can be a significant revenue driver for us. When it comes to nicotine pouches, you're correct, we're getting our products out into the market. We're figuring out the appropriate deployment model and the appropriate route to market. We'll take those learnings and put investment where we identify growth opportunities.
Pallav Mittal
analystUnderstood. If there's room for one final inquiry regarding Crown Switch and vapes — you mentioned a PMTA submission is coming at some point in this year, and with any luck a launch could happen at some point in the next year, in light of the FDA's most recent enforcement change. My own view is that it's possible a new product gets introduced within 6 to 9 months. What I'd like to know is how you intend to go head-to-head in the American market, considering how many of these illegal disposable vapes keep multiplying. If you could give us some insight into what that strategy might look like. Would it be highly focused — only a handful of cities, certain states? And what about the price point you're considering?
Stuart Brazier
executiveYeah. I'd say the timing estimates you just mentioned probably serve as a decent guide. Once more, the U.S. is clearly an enormous market. So at first, once again, we'll be targeting by geography as we continue building out our capability. During the second half of this year, we're putting money in to establish that route to market capability as well, in the place where we want to start launching. I'd say the fresh guidance the FDA has issued is quite encouraging. It seems they acknowledge that the way things are currently set up, or the way they've historically been set up, has been holding back new technologies from reaching the market and from competing in the legal market — which explains why you've seen this flood of new tech and flavors arriving in the U.S., and why the illicit segment has grown so big. Going forward, my expectation is that conditions will steadily improve as new tech becomes accessible in the legal market. We've observed lately that a number of manufacturers are starting to roll out flavors too. Those dynamics, I believe, will create a solid opportunity for serious manufacturers and those wanting to compete in the legal market — one that should expand over the midterm.
Gaurav Jain
executivePallav, I want to add something here. Sadly, a technical problem meant the slide deck didn't come through alongside the comments, but do take a look at it. On slide 10, you'll be able to see how far our Al Fakher brand reaches. That reach is enormous. I doubt many people realize this, yet measured by reach it ranks as the sixth biggest tobacco brand worldwide, and China isn't even counted in that figure. In my view, the consideration set we face differs greatly from the one our bigger competitors face, since cannibalization isn't something we deal with regarding NGCs. There's no need for us to weigh what margin the historical product currently earns versus what margin the new product earns, nor to ask whether cannibalization past some threshold makes things additive for us or not. My sense is that we enjoy considerable flexibility in the way we go after the market and in how we make use of the Al Fakher brand, which, incidentally, we already do across a number of our NGCs. Look at Crown Switch in Germany and you'll see the way we make use of it. To me, that represents an enormous opportunity for this company. Granted, it's a small market, and illicit product makes it particularly tough, but our position looks quite strong, and with Crown Switch plus the technology partnership we've now established with Greentank, we hold a rather distinctive product that ought to connect with consumers quite effectively.
Pallav Mittal
analystGot it; that is very clear. Thank you.
Operator
operatorThat concludes the Q&A portion of today's call, everyone. We appreciate your interest and your participation in this AIR Global conference. At this point, you're welcome to disconnect your lines, or log off the webcast, and enjoy the remainder of your day.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete AIR Global PLC transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to AIR Global PLC earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in AIR Global PLC or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.